Literature DB >> 1725104

Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.

W Dobryszycka1, J Gerber, J Zuwała-Jagiełło, M Ujec.   

Abstract

Serum levels of haptoglobin (HP), sialic acid total (NAN) and lipid-bound (NAL), seromucoid (SER), its content in total protein (%SER), as well as circulating immune complexes (CIC), were measured in sera of women with ovarian carcinoma, prior to their treatment and through the course of chemotherapy, remission and recurrence of malignancy, respectively. Control groups consisted of healthy women and patients with benign tumors (ovarian cysts and uterine myomas). Pretreatment measurements of acute phase reactants discriminated cancers (FIGO stages I+II, III, IV) from healthy group, however differences between benign tumors and stages of ovarian cancer were not so distinct. Changes in the examined parameters (acute phase reactants) indicated satisfactorily a response to the administered chemotherapy and early signs of the progression of the disease. Because of great variations in serum CIC concentrations, they were found to be of no value either in diagnosis or in the surveillance of the disease status.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725104

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  4 in total

1.  Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

Authors:  Changqing Zhao; Loganath Annamalai; Changfa Guo; Narasimhan Kothandaraman; Stephen Chee Liang Koh; Huoming Zhang; Arijit Biswas; Mahesh Choolani
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

2.  Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?

Authors:  Richard G Moore; Alexandra Blackman; M Craig Miller; Katina Robison; Paul A DiSilvestro; Elizabeth E Eklund; Robert Strongin; Geralyn Messerlian
Journal:  Gynecol Oncol       Date:  2019-04-13       Impact factor: 5.482

3.  Effect of radiotherapy on serum mucoprotein level in carcinoma Larynx and Pharynx.

Authors:  H R Mali; M L Bhatt; S M Natu; N Bhatia
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2001-01

4.  Potential markers for detection and monitoring of ovarian cancer.

Authors:  Brandon J D Rein; Sajal Gupta; Rima Dada; Joelle Safi; Chad Michener; Ashok Agarwal
Journal:  J Oncol       Date:  2011-04-11       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.